American Financial Group’s Journey Medical DERM Stock Holding History

American Financial Group’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Hold	180,000	–	–	0.45%	38
2026 Q1	$844K	Hold	180,000	–	–	0.31%	47
2025 Q4	$1.39M	Hold	180,000	–	–	0.5%	28
2025 Q3	$1.28M	Hold	180,000	–	–	0.49%	27
2025 Q2	$1.29M	Hold	180,000	–	–	0.48%	29
2025 Q1	$1.06M	Hold	180,000	–	–	0.45%	33
2024 Q4	$704K	Hold	180,000	–	–	0.32%	43
2024 Q3	$1.02M	Hold	180,000	–	–	0.44%	38
2024 Q2	$1.01M	Hold	180,000	–	–	0.44%	41
2024 Q1	$662K	Hold	180,000	–	–	0.25%	53
2023 Q4	$1.04M	Hold	180,000	–	–	0.38%	45
2023 Q3	$493K	Hold	180,000	–	–	0.17%	66
2023 Q2	$286K	Hold	180,000	–	–	0.09%	78
2023 Q1	$283K	Hold	180,000	–	–	0.09%	78
2022 Q4	$346K	Hold	180,000	–	–	0.12%	79
2022 Q3	$443K	Hold	180,000	–	–	0.15%	73
2022 Q2	$673K	Hold	180,000	–	–	0.23%	60
2022 Q1	$869K	Hold	180,000	–	–	0.26%	55
2021 Q4	$968K	Buy	+180,000	New	+$1.3M	0.27%	58

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

American Financial Group's DERM Position: Q2 2026 in Review

American Financial Group held its Journey Medical (DERM) position steady in Q2 2026 at 180,000 shares worth $1.27M. The position accounts for 0.45% of the portfolio, ranked #38.

American Financial Group first reported a position in DERM in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.39M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

American Financial Group held 180,000 shares of Journey Medical worth $1.27M as of Q2 2026.
American Financial Group left its Journey Medical share count unchanged in Q2 2026.
Journey Medical made up 0.45% of American Financial Group's portfolio in Q2 2026, its #38 holding.
American Financial Group first reported a position in Journey Medical in Q4 2021 and has held it in 19 quarters since.
American Financial Group's Journey Medical position peaked at $1.39M in Q4 2025.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on American Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.